Tue 21st July. 12.00 – 2.00. Screening Room, University of Edinburgh, 50 George Square, EH8 9JU
Novel psychoactive substances (NPS) include a wide range of “designer drugs” that have risen to prominence in the 21st century and become a source of clinical concern. The presentation will address mortality due to the two major classes of NPS, the synthetic cannabinoids and psychoactive stimulants/ hallucinogens. Data on the characteristics of fatalities, the circumstances of death, toxicology and major organ pathology will be presented.
Shane Darke is a Professor at the National Drug & Alcohol Research Centre and a leading world expert on the health effects associated with illicit drug use. He has authored more than 280 articles and four books. His specialist research area is drug-related harm, with a strong focus on mortality. He has published widely on overdose, suicide, psychopathology, trauma, treatment outcomes and toxicology.
Shane’s most recent book is The Clinician’s Guide to Illicit Drugs and Health, a comprehensive work that examines the health effects of each of the major illicit drugs. He is also the Regional Editor of Addiction for Australasia & Southeast Asia, and an Associate Editor of Drug & Alcohol Dependence.
This event will be of interest to anyone interested in learning about the impact of synthetic cannabinoids, novel psychostimulants / hallucinogens and other substances on mortality among people who use drugs.
Roy Robertson (Addiction medic & Professor of Addiction Medicine) will Chair this event which is co-organised by the Usher Institute, University of Edinburgh and the Drugs Research Network for Scotland.